Today's Low
₹ 521.05
Today's High
₹ 557.70
52 Weeks Low
₹ 222.60
52 Weeks High
₹ 471.00
Lower
₹ 432.40
Upper
₹ 648.60
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 768.0 | 887.2 | 862.5 | 623.9 | 545.1 | 672.0 | 729.9 | 354.2 | 327.6 | 233.7 | 212.0 | 187.9 | 178.4 | 94.3 | 72.1 |
Total Non-Current Assets | 2,134.4 | 1,988.3 | 1,729.6 | 1,365.4 | 1,065.0 | 827.2 | 742.3 | 576.7 | 576.8 | 443.9 | 339.2 | 245.0 | 159.8 | 153.5 | 148.6 |
Total Assets | 2,902.4 | 2,875.5 | 2,632.4 | 1,989.2 | 1,610.0 | 1,499.1 | 1,472.2 | 930.9 | 904.6 | 677.8 | 551.4 | 433.1 | 338.2 | 247.8 | 220.8 |
Total Current Liabilities | 782.9 | 611.5 | 587.5 | 410.8 | 253.4 | 265.8 | 236.9 | 222.1 | 189.1 | 166.8 | 123.8 | 121.1 | 80.2 | 56.2 | 38.6 |
Total Non-Current Liabilities | 345.1 | 452.8 | 561.4 | 256.9 | 166.6 | 153.5 | 251.3 | 67.2 | 154.2 | 104.5 | 98.5 | 31.1 | 31.9 | 90.4 | 123.5 |
Shareholder's Funds | 1,783.3 | 1,822.2 | 1,478.7 | 1,329.4 | 1,197.6 | 1,085.0 | 986.9 | 639.3 | 546.9 | 396.5 | 320.4 | 276.0 | 224.7 | 101.3 | 58.7 |
Total Liabilities | 2,902.4 | 2,875.5 | 2,632.4 | 1,989.2 | 1,610.0 | 1,499.1 | 1,472.2 | 930.9 | 904.6 | 677.8 | 551.4 | 433.1 | 338.2 | 247.8 | 220.8 |
The Industry Price to BV stands at 6.08, vs the Price to BV of 2.62, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.29, which results in a Negative aspect.
The Industry Current Ratio stands at 2.31, vs the Current Ratio of 1.52, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 0.97, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 1,050.1 | 1,145.5 | 901.1 | 907.9 | 733.4 | 788.8 | 779.2 | 716.4 | 613.8 | 571.4 | 371.3 | 318.2 | 290.3 | 264.9 | 166.4 | 95.8 |
Total Expenditure | 961.8 | 948.3 | 729.4 | 693.4 | 579.4 | 637.6 | 617.6 | 556.4 | 487.4 | 455.4 | 302.7 | 257.1 | 219.7 | 188.6 | 144.3 | 76.8 |
Operating Profit(Excl OI) | 119.7 | 218.1 | 211.8 | 236.7 | 169.6 | 183.8 | 191.0 | 171.4 | 133.4 | 125.1 | 74.7 | 69.4 | 79.5 | 82.3 | 23.2 | 21.5 |
Add: Other Income | 31.4 | 20.9 | 40.1 | 22.2 | 15.6 | 32.6 | 29.3 | 11.4 | 6.9 | 9.1 | 6.1 | 8.3 | 9.0 | 6.0 | 1.0 | 2.5 |
Operating Profit | 119.7 | 218.1 | 211.8 | 236.7 | 169.6 | 183.8 | 191.0 | 171.4 | 133.4 | 125.1 | 74.7 | 69.4 | 79.5 | 82.3 | 23.2 | 21.5 |
Less: Interest | 58.7 | 41.2 | 21.9 | 4.6 | 3.7 | 2.7 | 3.1 | 3.9 | 4.1 | 3.5 | 2.3 | 2.3 | 2.6 | 5.9 | 6.3 | 1.3 |
PBDT | 61.0 | 176.9 | 189.9 | 232.2 | 165.9 | 181.2 | 187.8 | 167.4 | 129.3 | 121.6 | 72.4 | 67.1 | 76.9 | 76.4 | 17.0 | 20.3 |
Less: Depreciation Amortization | 95.5 | 79.8 | 54.0 | 43.8 | 42.1 | 37.2 | 30.6 | 23.1 | 21.4 | 23.2 | 15.3 | 14.4 | 13.0 | 12.7 | 9.4 | 3.5 |
PBT & Exceptional Items | -34.5 | 97.1 | 136.0 | 188.4 | 123.8 | 144.0 | 157.2 | 144.3 | 107.9 | 98.4 | 57.1 | 52.7 | 64.0 | 63.7 | 7.6 | 16.8 |
Less: Exceptional Income Expenses | 0.0 | 8.8 | 60.8 | 0.0 | 19.9 | 0.0 | -4.5 | -2.4 | -0.1 | -2.9 | -0.1 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | -38.3 | 102.3 | 195.1 | 188.1 | 135.7 | 136.8 | 146.5 | 140.4 | 107.8 | 95.5 | 57.0 | 53.3 | 64.0 | 63.7 | 7.6 | 16.8 |
Less: Taxation | -7.4 | 41.7 | 48.9 | 33.5 | 26.2 | 33.9 | 42.0 | 35.6 | 35.2 | 20.3 | 9.5 | 12.2 | 14.6 | 21.1 | 8.6 | 5.4 |
Profit After Tax | -30.9 | 60.6 | 146.2 | 154.6 | 109.5 | 102.9 | 104.5 | 104.7 | 72.6 | 75.2 | 47.5 | 41.1 | 49.4 | 42.6 | -1.0 | 11.3 |
Earnings Per Share | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
The Industry Dividend Yield stands at 0.59, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PAT Margin stands at 9.70, vs the PAT Margin of 17.02, which results in a Positive aspect.
The Industry PE Ratio stands at 43.03, vs the PE Ratio of 0.00, which results in a Negative aspect.
The Industry PAT Growth stands at 32.16, vs the PAT Growth of 41.15, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | -38.3 | 102.3 | 195.1 | 188.1 | 135.7 | 136.8 | 146.5 | 140.4 | 107.8 | 95.5 | 57.0 | 53.5 | 64.1 | 63.7 | 7.6 |
Tax Paid | -32.4 | -34.5 | -47.6 | -42.2 | -36.1 | -41.0 | -33.6 | -29.6 | -25.4 | -21.6 | -11.0 | -7.7 | -12.6 | -12.4 | -4.6 |
Adjustment | 148.1 | 109.3 | 5.8 | 41.7 | 28.5 | 18.8 | 17.2 | 20.6 | 26.5 | 19.6 | 11.5 | 10.2 | 10.4 | 16.1 | 24.4 |
Changes In Working Capital | -38.3 | 102.3 | 195.1 | 188.1 | 135.7 | 136.8 | 146.5 | 140.4 | 107.8 | 95.5 | 57.0 | 53.5 | 64.1 | 63.7 | 7.6 |
Cash Flow after changes in Working Capital | 258.5 | 139.6 | 94.5 | 166.6 | 182.8 | 85.9 | 71.1 | 158.3 | 94.2 | 91.6 | 54.6 | 64.5 | 53.5 | 65.9 | 34.4 |
Cash Flow from Operating Activities | 226.2 | 105.1 | 46.9 | 124.4 | 146.8 | 44.9 | 37.5 | 128.7 | 68.8 | 70.0 | 43.6 | 56.7 | 40.9 | 53.5 | 29.7 |
Cash Flow from Investing Activities | -278.5 | -285.5 | -404.3 | -289.5 | -196.2 | -8.8 | -262.2 | -109.2 | -195.1 | -48.9 | -95.2 | -152.3 | 7.8 | -18.3 | -52.7 |
Cash Flow from Financing Activities | 45.8 | 82.9 | 436.4 | 175.5 | 10.1 | -60.9 | 312.7 | -19.7 | 136.2 | -28.3 | 66.3 | 10.0 | 35.9 | -36.7 | 12.4 |
Net Cash Inflow / Outflow | -6.5 | -97.5 | 79.0 | 10.4 | -39.3 | -24.7 | 88.0 | -0.2 | 9.9 | -7.2 | 14.7 | -85.6 | 84.6 | -1.4 | -10.5 |
Opening Cash & Cash Equivalents | 25.3 | 122.8 | 44.3 | 34.1 | 73.8 | 100.0 | 7.1 | 3.6 | 9.2 | 16.9 | 2.3 | 87.8 | 2.6 | 3.8 | 14.6 |
Closing Cash & Cash Equivalent | 18.8 | 25.3 | 123.3 | 44.3 | 34.4 | 73.8 | 100.0 | 6.4 | 18.4 | 9.2 | 16.9 | 2.3 | 87.2 | 2.3 | 4.1 |
The Industry PFCF Ratio stands at 25.35, vs the PFCF Ratio of -9.31, which results in a Negative aspect.
The Industry PCF RATIO stands at 24.35, vs the PCF RATIO of 16.03, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2,864.8 | 3,129.8 | 2,601.8 | 2,635.6 | 2,625.0 | 2,629.1 | 2,611.6 | 3,406.0 | 2,723.0 | 2,952.7 | 2,373.6 | 2,080.3 | 1,912.5 | 2,789.4 | 2,228.7 | 2,199.9 |
Total Income | 2,887.0 | 3,147.9 | 2,621.1 | 2,657.3 | 2,652.4 | 2,672.9 | 2,692.6 | 3,460.9 | 2,777.8 | 2,965.5 | 2,393.5 | 2,149.4 | 1,998.6 | 2,881.4 | 2,283.5 | 2,289.0 |
Total Expenditure | 2,205.4 | 2,526.8 | 2,122.6 | 2,253.4 | 2,312.1 | 2,507.1 | 2,405.9 | 2,668.7 | 2,272.1 | 2,421.1 | 2,054.8 | 1,818.2 | 1,702.8 | 2,102.5 | 1,571.1 | 1,744.0 |
PBIDT (Excl OI) | 659.5 | 603.0 | 479.2 | 382.3 | 312.9 | 122.0 | 205.7 | 737.3 | 450.9 | 531.6 | 318.8 | 262.1 | 209.7 | 686.8 | 657.5 | 456.0 |
Other Income | 22.1 | 18.1 | 19.3 | 21.7 | 27.4 | 43.9 | 81.0 | 54.9 | 54.8 | 12.8 | 19.9 | 69.1 | 86.1 | 92.0 | 54.8 | 89.1 |
Operating Profit | 681.6 | 621.1 | 498.5 | 404.0 | 340.3 | 165.8 | 286.7 | 792.2 | 505.7 | 544.4 | 338.7 | 331.2 | 295.8 | 778.9 | 712.3 | 545.1 |
Interest | 262.2 | 232.4 | 181.5 | 177.4 | 178.6 | 134.7 | 95.9 | 93.5 | 99.2 | 115.8 | 103.2 | 91.2 | 48.0 | 39.5 | 40.0 | 10.1 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 | 0.0 | 89.1 | 0.0 | 0.0 | 0.0 | 0.0 | 608.4 | -3.8 |
PBDT | 419.4 | 388.7 | 317.0 | 226.6 | 161.7 | 31.1 | 190.9 | 697.6 | 406.5 | 517.7 | 235.5 | 240.0 | 247.8 | 739.3 | 1,280.7 | 531.2 |
Depreciation | 267.1 | 277.9 | 267.5 | 256.9 | 240.8 | 233.1 | 224.2 | 223.4 | 206.5 | 191.8 | 176.3 | 152.3 | 137.2 | 127.0 | 123.3 | 115.5 |
Profit Before Tax | 152.3 | 110.8 | 49.5 | -30.3 | -79.1 | -202.0 | -33.4 | 474.1 | 200.0 | 325.9 | 59.2 | 87.6 | 110.5 | 612.3 | 1,157.4 | 415.7 |
Tax | 94.6 | 76.0 | 21.1 | 38.2 | -9.6 | -38.1 | -64.1 | 168.6 | 97.1 | 115.6 | 35.6 | 8.0 | 29.2 | 159.9 | 291.4 | 75.5 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 57.7 | 34.8 | 28.4 | -68.5 | -69.5 | -163.8 | 30.8 | 305.5 | 102.9 | 210.3 | 23.6 | 79.7 | 81.4 | 452.4 | 866.0 | 340.2 |
Net Profit | 57.7 | 34.8 | 28.4 | -68.5 | -69.5 | -163.8 | 30.8 | 305.5 | 102.9 | 210.3 | 23.6 | 79.7 | 81.4 | 452.4 | 866.0 | 340.2 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 86.8 | 86.8 | 86.8 | 86.8 | 86.8 | 86.8 | 86.8 | 86.8 | 86.8 | 81.5 | 81.5 | 81.5 | 81.5 | 81.5 | 81.5 | 81.5 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 0.5 | 0.2 | 0.1 | -0.9 | -0.8 | -2.2 | 0.1 | 3.4 | 1.1 | 2.5 | 0.2 | 1.0 | 0.9 | 5.6 | 10.6 | 4.2 |
Operating Profit Margin | 23.8 | 19.8 | 19.2 | 15.3 | 13.0 | 6.3 | 11.0 | 23.3 | 18.6 | 18.4 | 14.3 | 15.9 | 15.5 | 27.9 | 32.0 | 24.8 |
Net Profit Margin | 2.0 | 1.1 | 1.1 | -2.6 | -2.6 | -6.2 | 1.2 | 9.0 | 3.8 | 7.1 | 1.0 | 3.8 | 4.3 | 16.2 | 38.9 | 15.5 |
The Industry Mcap Growth stands at 19.73, vs the Mcap Growth of -28.13, which results in a Negative aspect.
The Industry Net Sales Growth stands at 11.05, vs the Net Sales Growth of 23.80, which results in a Positive aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 624.40 | 658.06 | 563.57 |
R3 | 597.90 | 603.43 | 552.04 |
R2 | 571.40 | 574.16 | 548.19 |
R1 | 555.95 | 561.48 | 544.35 |
Pivot | 529.45 | 532.21 | 529.45 |
S1 | 514.00 | 519.53 | 536.65 |
S2 | 487.50 | 490.26 | 532.81 |
S3 | 472.05 | 477.58 | 528.96 |
S4 | 456.60 | 406.36 | 517.43 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
35.89
Neutral
RSI
65.75
Neutral
ROC
15.52
Bullish
UltimateOscillator
47.43
Neutral
Williams Indicator
-28.48
Neutral
CCI Indicator
102.70
Bearish
MACD
-2,589.98
Bearish
Stochastic Indicator
79.51
Neutral
ATR
25.04
Low Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
19-09-2022 | 1.10 | 110 | Final |
20-09-2021 | 1.10 | 110 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
08-02-2024 | Rights Issue & Quarterly Results & Preferential Issue of shares |
10-11-2023 | Quarterly Results |
10-08-2023 | Quarterly Results |
23-06-2023 | Right Issue of Equity Shares Inter alia, to consider proposal of fund raising by way of Rights issue of Equity Shares, subject to such Regulatory/ Statutory approvals as may be required. |
25-05-2023 | Audited Results |
14-02-2023 | Quarterly Results |
11-11-2022 | Quarterly Results |
11-08-2022 | Quarterly Results |
23-05-2022 | Quarterly Results & Dividend & Audited Results |
08-02-2022 | Quarterly Results |
29-10-2021 | Quarterly Results |
14-10-2021 | Preferential Issue of shares & Issue Of Warrants Inter alia to consider the issue of Equity Shares and/or convertible securities including warrants on Preferential basis under SEBI (ICDR) Regulations, 2018, including determination of issue price as may be permitted under applicable laws, subject to such regulatory / statutory approvals as may be required including approval of shareholders of the Company. |
14-08-2021 | Quarterly Results |
31-05-2021 | Quarterly Results & Audited Results |